PEAK1 and neoplasm: In this study, we provide conclusive experimental evidence that the absence of PEAK1 in intestinal epithelial cells disrupts the architecture of tight junctions and augments susceptibility to experimental colitis (Figs. 1, 7), expanding PEAK1’s roles beyond promoting tumor cell proliferation and migration to essential physiological processes.